Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial HJL Heerspink, J Radhakrishnan, CE Alpers, J Barratt, S Bieler, U Diva, ... The Lancet 401 (10388), 1584-1594, 2023 | 122 | 2023 |
Ultrasound-assessed diaphragmatic impairment is a predictor of outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease undergoing noninvasive … A Marchioni, I Castaniere, R Tonelli, R Fantini, M Fontana, L Tabbì, ... Critical care 22, 1-9, 2018 | 95 | 2018 |
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial BH Rovin, J Barratt, HJL Heerspink, CE Alpers, S Bieler, DW Chae, ... The Lancet 402 (10417), 2077-2090, 2023 | 79 | 2023 |
Acid base disorders in patients with COVID-19 G Alfano, F Fontana, G Mori, F Giaroni, A Ferrari, S Giovanella, G Ligabue, ... International urology and nephrology 54 (2), 405-410, 2022 | 67 | 2022 |
SARS-CoV-2 infection in dialysis patients in northern Italy: a single-centre experience F Fontana, F Giaroni, M Frisina, G Alfano, G Mori, L Lucchi, R Magistroni, ... Clinical Kidney Journal 13 (3), 334-339, 2020 | 29 | 2020 |
Serial ultrasound assessment of diaphragmatic function and clinical outcome in patients with amyotrophic lateral sclerosis R Fantini, R Tonelli, I Castaniere, L Tabbì, MR Pellegrino, S Cerri, ... BMC Pulmonary Medicine 19, 1-8, 2019 | 28 | 2019 |
Incidence of nephrogenic systemic fibrosis after administration of gadoteric acid in patients on renal replacement treatment G Alfano, F Fontana, A Ferrari, A Solazzo, R Perrone, F Giaroni, ... Magnetic Resonance Imaging 70, 1-4, 2020 | 19 | 2020 |
Clinical Predictors of Nondiabetic Kidney Disease in Patients with Diabetes: A Single‐Center Study F Fontana, R Perrone, F Giaroni, G Alfano, S Giovanella, G Ligabue, ... International Journal of Nephrology 2021 (1), 9999621, 2021 | 14 | 2021 |
One‐year persistence of neutralizing anti‐SARS‐CoV‐2 antibodies in dialysis patients recovered from COVID‐19 G Alfano, F Fontana, N Morisi, F Giaroni, G Mori, G Guaraldi, R Magistroni, ... Hemodialysis International 25 (4), E53-E56, 2021 | 11 | 2021 |
Automated prediction of kidney failure in IgA nephropathy with deep learning from biopsy images F Testa, F Fontana, F Pollastri, J Chester, M Leonelli, F Giaroni, F Gualtieri, ... Clinical Journal of the American Society of Nephrology 17 (9), 1316-1324, 2022 | 8 | 2022 |
AKI in hospitalized patients with COVID-19: a single-center experience G Alfano, S Giovanella, F Fontana, J Milic, G Ligabue, N Morisi, F Giaroni, ... G. Ital. Di Nefrol 5, 2021 | 7 | 2021 |
Seroconversion after COVID-19 vaccine in a dialysis patient on immunosuppressants G Alfano, F Fontana, G Mori, S Giovanella, F Giaroni, G Ligabue, ... Clinical Kidney Journal 14 (8), 1983-1984, 2021 | 4 | 2021 |
Effects of immunosuppressive therapy reduction and early post-infection graft function in kidney transplant recipients with COVID-19 G Alfano, F Damiano, F Fontana, C Ferri, F Giaroni, A Melluso, M Montani, ... medRxiv, 2021.06. 06.21258414, 2021 | 4 | 2021 |
Similar Rates of AKI during the First Two Waves of COVID-19 in Northern Italy: a single-center study G Alfano, S Giovanella, F Fontana, J Milic, G Ligabue, F Giaroni, C Ferri, ... medRxiv, 2021.06. 13.21258862, 2021 | 1 | 2021 |
Rituximab in people living with HIV affected by immune-mediated renal diseases: a case-series G Alfano, F Giaroni, F Fontana, L Neri, G Mosconi, C Mussini, G Guaraldi, ... International journal of STD & AIDS 31 (14), 1426-1431, 2020 | 1 | 2020 |
Combining telemedicine and in-person visits to deliver care to patients with severe chronic kidney disease (CKD): Lessons learned from COVID-19. G Alfano, S Cazzato, L Diotallevi, F Giaroni, F Fontana, S Giovanella, ... Clinical Nephrology, 2024 | | 2024 |
Risk of bleeding after percutaneous native kidney biopsy in patients receiving low-dose aspirin: a single-center retrospective study F Fontana, S Cazzato, F Giaroni, F Bertolini, G Alfano, G Mori, ... Journal of Nephrology 36 (2), 475-483, 2023 | | 2023 |
BLEEDING COMPLICATIONS AFTER ALLOGRAFT KIDNEY BIOPSY AND ROLE OF ANTIPLATELET THERAPY S Cazzato, F Fontana, F Giaroni, F Bertolini NEPHROLOGY DIALYSIS TRANSPLANTATION 37, I71-I72, 2022 | | 2022 |
MO200: Risk of Complications after Percutaneous Native Kidney Biopsy in Patients Receiving Anti-Platelet Agents F Fontana, S Cazzato, F Giaroni, G Alfano, G Cappelli, G Donati Nephrology Dialysis Transplantation 37 (Supplement_3), gfac066. 102, 2022 | | 2022 |
MO122: Bleeding Complications after Allograft Kidney Biopsy and Role of Antiplatelet Therapy S Cazzato, F Fontana, F Giaroni, F Bertolini Nephrology Dialysis Transplantation 37 (Supplement_3), gfac066. 025, 2022 | | 2022 |